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Cardiovascular diseases (CVDs) are important medical and public health issues throughout the world. This is a bigger problem for developing countries like Nigeria which face the dual menace of high prevalence of communicable diseases as well as an increasing burden of noncommunicable diseases such as cardiovascular illnesses.\[[@ref1][@ref2]\]

The incidence of CVDs in developing countries has been on the increase in the last few years.\[[@ref3]\] This rise has been attributed to demographic changes, urbanization, lifestyle modifications, and high-risk factors such as obesity, dyslipidemias, diabetes mellitus, hypertension.\[[@ref3]\]

Between 1990 and 2020, the rise in mortality due to ischemic heart diseases (IHDs) in developing countries (137% men, 120% women) is predicted to be much higher than that in the developed countries (48% men, 29% women).\[[@ref4]\] It is also projected that in the next 15 years, CVDs will become the leading cause of death in developing countries.

Epidemiological data on cardiovascular disorders are generally lacking in the developing nations. However, various hospital-based studies that show the pattern of CVDs have been documented in some regions. In a study of the pattern of medical admissions within a 5-year period (December 1998--November 2003) at the University of Nigeria Teaching Hospital, Enugu, Nigeria, among 7399 patients admitted, CVDs accounted for 18.8% with 53% within ages 30--60 years, with male and female ratio of 1.4:1.\[[@ref5]\] Furthermore, in Nigeria, Ansa *et al*.\[[@ref6]\] reported 19.9% prevalence of cardiovascular admissions in the University of Uyo Teaching Hospital. In recent years, studies have examined the pattern of admissions to medical wards in various countries,\[[@ref7][@ref8]\] but comparison between two countries with different social, economic, and health indices is scarce in the literature. Hence, we studied the indications, frequencies, and distribution of cardiovascular admissions into medical wards of Sheba Medical Centre, Israel, and Federal Medical Centre (FMC), Umuahia, Nigeria, and compared the results.

Sheba Medical Centre is a tertiary health care institution in Israel. It is a 1700-bedded and the largest hospital in the Middle East. It has about 6000 health professionals, of which 850 are doctors and 2000 are nurses. It handles about 4 million patients annually and has 120 departments. Division of Internal Medicine in this hospital has 266 beds for inpatients and 72 day beds for outpatients.

FMC, Umuahia, is a tertiary health care institution situated in Umuahia, the capital city of Abia State of Nigeria. It was founded on March 24, 1956, and was named Queen Elizabeth Hospital after the Queen of England, and subsequently made an FMC. It is a medium-sized 405-bedded hospital with 80 beds in the medical wards.
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We conducted a retrospective study, in which we collected data on admissions with CVDs into the medical wards of FMC, Umuahia, over a 4-year period (January 2005--December 2008) using the register of admissions and discharges in both male and female medical wards, as well as a review of the patients' case files where necessary.

A retrospective survey of cardiovascular admissions in the medical wards of the Sheba Hospital was undertaken for 2006 and 2007 using ward record books. Information retrieved included age, diagnosis, and year of admission. Records of all patients with cardiovascular admissions were retrieved and included in the study while those with incomplete data were excluded from the study.

Ethical clearance was obtained for the study. Data obtained were analyzed using Statistical Package for Social Sciences (SPSS) version 16 (International Business Machines (IBM) Corporation, New York USA). Tables were used for descriptive analysis. A *P* \< 0.05 was taken to be statistically significant.
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There were 700 cardiovascular admissions in the 4-year period in FMC, Umuahia, which constituted 20.1% of all (3483) medical admissions.

There were 22,264 cardiovascular admissions to Sheba Medical Centre over the 2-year period, which constituted 41.2% of all their medical admissions with an annual average of 27,020.

The age distribution studied in FMC, Umuahia, and Sheba Medical Centre is as shown in [Table 1](#T1){ref-type="table"}. In Sheba, the indications were more precise and of wider spectrum (up to 79 indications). These indications have been grouped and compared with the admissions in FMC, Umuahia, as shown in [Table 2](#T2){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}.

###### 

Age distribution of cardiovascular admissions

  Age (years)   Frequency (%)   *P*             
  ------------- --------------- --------------- ----------
  15-34         64 (9.1)        334 (1.5)       0.001\*
  35-50         140 (20)        4430 (19.9)     0.946
  51-74         357 (51)        11,778 (52.9)   0.321
  ≥75           139 (19.9)      5722 (25.7)     0.0004\*
  Total         700 (100)       22,264 (100)    

\*Statistically significant. FMC=Federal Medical Centre

###### 

Yearly average number of cardiovascular disease admissions (Umuahia vs. Sheba)

  Cardiovascular disease               Frequency (%)   *P*            
  ------------------------------------ --------------- -------------- ---------------
  Aneurysm                             0               49 (0.41)      1^\#^
  Cardiomyopathy                       2 (1.10)        431 (3.58)     0.0965^\#^
  Carditis                             0               577 (4.79)     0.0004^\#,^\*
  Cor-pulmonale                        2 (1.10)        238 (1.96)     0.5888^\#^
  Dysrhythmia                          3 (1.7)         1493 (12.39)   0.0001^\#,^\*
  Heart failure                        64 (36.6)       573 (4.76)     0.0001\*
  Hypertension                         95 (54.3)       2160 (17.93)   0.001\*
  Hypertensive heart disease           5 (3)           3 (0.03)       0.001^\#,^\*
  Ischemic heart disease               2 (1.1)         6090 (50.5)    0.0001\*
  Peripheral vascular disease          0               282 (2.34)     0.0365^\#,^\*
  Valvular heart disease               2 (1.1)         72 (0.6)       0.2862^\#^
  Ill-defined cardiovascular disease   0               81 (0.67)      0.6331^\#^
  Total                                175 (100)       12,049 (100)   

^\#^Fisher's exact *P* value, \*Significant association. FMC=Federal Medical Centre

![Frequencies (%) of CVD admissions in Umuahia Vs Sheba](AAM-16-70-g001){#F1}

D[iscussion]{.smallcaps} {#sec1-4}
========================

This study provides insight into the differences in cardiovascular admissions between a developed and a developing country. The spectrum of cardiovascular conditions is limited in the data from FMC, Umuahia. This was due to comparative deficiency in specialization and investigative technology at the Nigerian center. In particular, this study was done at a time when echocardiography, a very helpful tool in ascertaining precise diagnosis of various cardiac conditions, was not domiciled in FMC, Umuahia, but could be accessed in nearby diagnostic facilities.

In both centers, age group most affected was 51--74 years, 51.2% for Umuahia and 52.9% for Sheba. Number of admissions of patients ≥75 years was significantly more in Sheba than in Umuahia. This may be because of increased life expectancy in Israel compared to Nigeria.\[[@ref9]\]

In FMC, Umuahia, CVDs constituted 20.1% of all medical admissions. This prevalence compares well with other studies done in different parts of Nigeria: 18.8% in Enugu, South-east Nigeria,\[[@ref5]\] 19.9% in Uyo, South Nigeria,\[[@ref6]\] 17.4% Abeokuta, Southwest Nigeria,\[[@ref10]\] and 14.1%--24.2% in Northern Nigeria.\[[@ref11]\] The prevalence of 8% reported in Kaduna (Northern Nigeria)\[[@ref12]\] was in the 1970s before the increasing trend in CVD burden in the developing nations was recorded. This trend has been documented in Nigeria and other developing nations.\[[@ref11][@ref13][@ref14][@ref15]\]

The prevalence of 41.2% in Sheba Medical Centre should reflect that of the country, considering the size of this hospital, in comparison to Israeli population of 7.8 million. Similar prevalence is found in other developed countries.\[[@ref16]\] This suggests that the burden of CVD admissions in Israel (a developed country) is more than in Nigeria (a developing country).

Most prevalent indications for cardiovascular admissions in FMC, Umuahia, were hypertension high blood pressure (HBP) 54.6% and heart failure (HF) 36.8%. This agrees with majority of works done in Nigeria. Reports obtained in various Nigerian centers were as follows: Abeokuta, Southwest - HBP 49.5%, HF 44.9%;\[[@ref10]\] Ile-Ife, Southwest - HBP 32%, HF 35%;\[[@ref17]\] Uyo, South-south - HBP 55.7%, HF 44.9%;\[[@ref6]\] North - HBP 39.1% was most prevalent in North-west. Most prevalent indication for CVD admissions in Sheba was IHD - 54.8% and hypertension - 19.4%. Similar pattern is seen in most developed countries.\[[@ref18]\]

Considering the epidemiologic transition going on in developing countries, follow-up studies are needed, especially as many workers have documented significant increase in the prevalence of cardiovascular risk factors in developing countries.\[[@ref19][@ref20][@ref21][@ref22][@ref23]\] This may soon translate into increase and changes in spectrum of cardiovascular admissions.
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There were more patients with CVD as a cause of medical admission in Israel compared with Umuahia, Nigeria. The most prevalent indication for cardiovascular admission in Nigeria (a developing country) was hypertension and HF while in Israel (a developed country), they were IHD and hypertension. Efforts made toward optimal control of hypertension and lifestyle modification will go a long way in reducing the burden of cardiovascular admissions.

Future studies are needed to monitor the spectrum and frequency of cardiovascular admissions in view of the epidemiological transition changing epidemiological profile.
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